THE WHAT? Beekman 1802 has named Jill Scalamandre CEO, replacing Tomei Thomas who will now serve as the company’s COO. Scalamandre serves as Chairwoman of the Cosmetics Executive Women organization and has more than 20 years of experience in leadership roles at global brands including Shiseido, Coty, Avon and Revlon.
THE DETAILS In her new role, Scalamandre is charged with accelerating company growth, propelling international expansion and driving product innovation for the microbiome skin care brand.
“I am thrilled to be joining as CEO,” said Scalamandre. “The Beekman 1802 team has built an incredibly solid brand foundation rooted in authenticity, kindness, and products that revolutionise clean skin care with goat milk science. This has come together to deliver an inspiring brand – one incredibly well-positioned for the interests and demands of today’s global consumer. By leveraging my experience, I am honored to help Beekman 1802 capitalize on its exciting next chapter of growth.
THE WHY? Brent Ridge, Beekman 1802 Co-founder, revealed, “The next phase of growth for Beekman 1802 is pivotal. We are confident that Ms Scalamandre’s vision, leadership and deep understanding of strategic growth will enable us to reach consumers on a global scale, lead innovation around microbiome skin care and spread our mission of kindness across the world.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
